ObsEva Competitors and Similar CompaniesClear all

ObsEva's competitors and similar companies include Durect and Affimed N.V..

	ObsEva ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.	Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.	Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Founding Date	Founding Date 2012	Founding Date N/A	Founding Date 2000
Type	Type Private	Type Public	Type Public
Tags	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma
Locations	Locations Plan-les-Ouates, CH HQ Boston, US Sacramento, US	Locations Cupertino, US HQ	Locations Heidelberg, DE HQ
Employees	Employees 811% decrease	Employees 902% increase	Employees 76
Valuation ($)	Valuation ($) N/A	Valuation ($) 45.3 m	Valuation ($) 52.5 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $2m (FY, 2024)	Revenue (est.) €8.3m (FY, 2023)
Cost of goods	Cost of goods N/A	Cost of goods $78k (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $2m (FY, 2024)	Gross profit €13m (FY, 2023)
Net income	Net income N/A	Net income ($8.3m) (FY, 2024)	Net income (€105.9m) (FY, 2023)
Funding
Total funding raised	Total funding raised $ 92.9m	Total funding raised $ 20m	Total funding raised N/A